| July 2023 | New Article: Fiedler et al. developed a novel methodology for vitamin B6 diagnostics. We supported the project by the production of custom antibody microarray targeting signature human PLP-DE and testing respective samples.

| Mai 2023 | New Article: Galadima et al. used the scioCD assay to analyse canine blood samples in the context of mammary neoplasia. The proteins CD20, CD45RA and CD99 were found at altered levels. The findings were validated by Western Blotting and are suggested as novel serum biomarkers.

Kyriaki Barmpa

PhD Candidate, Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine, University of Luxembourg

"By collaborating with Sciomics, we conducted a detailed analysis of the proteome of striatum organoids, uncovering significant differences that further assisted our research. Their communication was highly efficient, and the results were delivered promptly."

Product: scioPhospho

At Sciomics, we are dedicated to advancing healthcare through proteomics research. We are collaborating with research groups and big pharma, alongside our in-house biomarker research initiatives. To make this research more accessible to you, we are launching the new Sciomics science blog!

The first study we will feature was published this year in a journal in the Nature publishing group. It's a topic that affects us all. Any guesses? Stay tuned!

Powering breakthrough research using Multiomics

Singleron and Sciomics – Collaborating in the pursuit of Precision Medicine

Singleron Biotechnologies and Sciomics have a common goal: Precision Medicine. Their scientific approaches, however, seem to come from two sides of a coin. Consequently, their strategic alliance is expected to reach complementary and interlocking scientific findings in the quest of holistic disease research.

Cologne and Heidelberg, Germany, 30 May 2023

Singleron Biotechnologies, a front-runner in single cell multi-omics sequencing solutions and Sciomics, a first-class provider of explorative proteomic and post translational modification profiling platforms, announce their collaboration to advance Precision Medicine.

Singleron Biotechnologies is an innovative single cell sequencing solution provider with a focus on molecular diagnostics. They apply ground-breaking single cell analysis techniques for clinical diagnosis, drug development, and health management. Sciomics’ powerful proteomic and post-translational modification profiling platform provides in-depth insights on protein levels to clients from biotech and pharma industry and is internally used to develop innovative biomarker signatures.

“At Singleron we believe that single cell sequencing and analysis is vital to understand complex disease mechanisms to evolve increasingly individualized medicine” said Dr. Andreas Schmidt, Senior Vice President of Global Business Development at Singleron. “This new relationship between Singleron and Sciomics offers a synergistic approach to understand the multiple layers of cellular regulation”.

“Over the last decade we developed an efficient and robust platform for profiling protein levels and phosphorylation status.”, said Dr. Christoph Schröder, Chief Executive Officer at Sciomics. “By combining multiple omics technologies, we believe significant advances can be facilitated in the area of precision medicine.”

Together, their strategically combined expertise integrates single cell analyses with cutting-edge technology for biomarkers, profiling pathway activity and soluble markers and is expected to deliver innovative and novel insights accelerating advancements in personalized medicine promoting human health.

About Singleron

Founded in 2018, Singleron develops and commercializes single cell multi-omics products that can be used in both research and clinical settings. Its current product portfolio includes instruments, microfluidic devices, reagents, software analysis and database solutions that facilitate high-throughput single cell analysis. Singleron’s sample services offer expert execution and generation of high-quality results for academia, clinics, and biotech.

The company currently has offices, laboratories, and manufacturing facilities in Germany, Singapore, China, and the US. Its products are used in over 2,000 laboratories in hospitals, research institutes, and pharmaceutical companies.

About Sciomics

Sciomics has extensive expertise in the field of biomarker discovery, in vitro and in vivo. Their model system characterisation and disease mechanism profiling use high-content protein and post-translational modification profiling. Currently, this results in over 1,400 analysed proteins by using their proprietary fully immuno-based scioDiscover antibody array platform in a single assay with minimal sample requirements combined with Machine Learning assisted data analysis. The high-content and high-throughput platform guarantees robust and reproducible results which can be easily translated into validation and clinical assays. Sciomics serves customers world-wide, focussing on the European and North American market.

Media contacts

This email address is being protected from spambots. You need JavaScript enabled to view it.

This email address is being protected from spambots. You need JavaScript enabled to view it.

| April 2023 | New Article: In a protein biomarker development project initiated by Sciomics, we have identified protein biomarker panels predicting development of a severe Covid.19  disease.

Please find below selected patents and scientific publications on our antibody microarray platform or its application in biomedical studies published in peer-reviewed journals. The articles were either published by our collaborators or customers or by Sciomics team. You will also find information on presentations at scientific conferences. 

Selected Scientific Publications by our Customers and Partners

2024

• Sigdel, T.K., Sur, S., Boada, P. et al. (2024)
  Proteome Analysis for Inflammation Related to Acute and Convalescent Infection. Inflammation 47, 346–362 (2024). https://doi.org/10.1007/s10753-023-01913-3

2023

• Fiedler MK, Drechsel J, Schmidt R, Luppa PB, Bach NC, Sieber SA. (2023)
  Rapid Diagnostic Platform for Personalized Vitamin B6 Detection in Erythrocytes via PLP Cofactor Mimics.
  ACS Chem Biol. Jul 5. doi: 10.1021/acschembio.3c00279. Epub ahead of print.
• Galadima, M.; Kotova, I.; Schmidt, R.; Pastor, J.; Schröder, C.; Rodríguez-Gil, J.E.; del Alamo, M.M.R. (2023)
  Canine Mammary Neoplasia Induces Variations in the Peripheral Blood Levels of CD20, CD45RA, and CD99. 
  Int. J. Mol. Sci., 24, 9222. https://doi.org/10.3390/ijms24119222
• Vid Janša, Maja Pušić Novak, Helena Ban Frangež, Tea Lanišnik Rižner (2023)
  TGFBI as a candidate biomarker for non-invasive diagnosis of early-stage endometriosis, Human Reproduction, Volume 38, Issue 7, July 2023, Pages 1284–1296, https://doi.org/10.1093/humrep/dead091
• Kundu, S., Nunes, L., Adler, J. et al. (2023)
  Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells.
  Cell Commun Signal 21, 354 (2023). https://doi.org/10.1186/s12964-023-01378-9
• Romano A, Rižner TL, Werner HMJ, Semczuk A, Lowy C, Schröder C, Griesbeck A, Adamski J, Fishman D and Tokarz J (2023)
  Endometrial cancer diagnostic and prognostic algorithms based on proteomics, metabolomics, and clinical data: a systematic review. Front. Oncol. 13:1120178. doi: 10.3389/fonc.2023.1120178
• Taylor, J., Uhl, L., Moll, I. et al. (2023)
  Endothelial Notch1 signaling in white adipose tissue promotes cancer cachexia. Nat Cancer 4, 1544–1560 (2023). https://doi.org/10.1038/s43018-023-00622-y
• Tintelnot, J., Xu, Y., Lesker, T.R. et al. (2023)
  Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615, 168–174 (2023). https://doi.org/10.1038/s41586-023-05728-y
• Wiedmann, L., De Angelis Rigotti, F., Vaquero-Siguero, N., Donato, E., Espinet, E., Moll, I., Alsina-Sanchis, E., Bohnenberger, H., Fernandez-Florido, E., Mülfarth, R., Vacca, M., Gerwing, J., Conradi, L. C., Ströbel, P., Trumpp, A., Mogler, C., Fischer, A., & Rodriguez-Vita, J. (2023) 
  HAPLN1 potentiates peritoneal metastasis in pancreatic cancer. 
  Nature communications, 14(1), 2353. https://doi.org/10.1038/s41467-023-38064-w

2022

• Abdulkhalikova D, Sustarsic A, Vrtačnik Bokal E, Jancar N, Jensterle M and Burnik Papler T. (2022)
  The Lifestyle Modifications and Endometrial Proteome Changes of Women With Polycystic Ovary Syndrome and Obesity.
  Front Endocrinol. 13:888460. doi:10.3389/fendo.2022.888460.
• Franz S, Ertel A, Engel KM, Simon JC, Saalbach A. (2022)
  Overexpression of S100A9 in obesity impairs macrophage differentiation via TLR4-NFkB-signaling worsening inflammation and wound healing.
  Theranostics. 12(4):1659-1682. doi:10.7150/thno.67174. 
• Groetsch B., Schachtschabel E., Tripal P., Schmid B., Smith A., Schett G.A. and Bozec A. (2022)
  Inflammatory activation of FcgR and IFNgR pathways co-influence the differentiation and activity of osteoclasts.
  Front. Immunol. 13:958974. doi:10.3389/fimmu.2022.958974
• Labes R, Brinkmann L, Kulow VA, Roegner K, Mathia S, Balcerek B, Persson PB, Rosenberger C and Fähling M.  (2022)
  Daprodustat prevents cyclosporine-A mediated anemia and peritubular capillary loss.
  Kidney Int. S0085-2538(22)00375-1. doi:10.1016/j.kint.2022.04.025. 
• Marino, D., Pizzi, M., Kotova, I., Schmidt, R., Schröder, C., Guzzardo, V., Talli, I., Peroni, E., Finotto, S., Scapinello, G., Dei Tos, A.P., Piazza, F., Trentin, L., Zagonel, V. and Piovan, E., (2022)
  High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients.
  Cancers 14. https://doi.org/10.3390/cancers14020338
• Pušić M, Klančič T, Knific T, Vogler A, Schmidt R, Schröder C and Lanišnik Rižner T. (2022)
  Antibody Arrays Identified Cycle-Dependent Plasma Biomarker Candidates of Peritoneal Endometriosis.
  J Pers Med. 12(6):852. doi: 10.3390/jpm12060852.
• Watson, C.N., Begum, G., Ashman, E., Thorn, D., Yakoub, K.M., Hariri, M.A., Nehme, A., Mondello, S., Kobeissy, F., Belli, A. and Di Pietro, V.,  (2022)
  Co-Expression Analysis of microRNAs and Proteins in Brain of Alzheimer’s Disease Patients.
  Cells 11, 163. https://doi.org/10.3390/cells11010163

2021

• Awwad, M.H.S., Mahmoud, A., Bruns, H., Echchannaoui, H., Kriegsmann, K., Lutz, R., Raab, M.S., Bertsch, U., Munder, M., Jauch, A., Weisel, K., Maier, B., Weinhold, N., Salwender, H.J., Eckstein, V., Hänel, M., Fenk, R., Dürig, J., Brors, B., Benner, A., Müller-Tidow, C., Goldschmidt, H., Hundemer, M., (2021)
  Selective elimination of immunosuppressive T cells in patients with multiple myeloma.
  Leukemia 35, 2602–2615. https://doi.org/10.1038/s41375-021-01172-x
• Fomitcheva-Khartchenko, A., Rapsomaniki, M.A., Sobottka, B., Schraml, P., Kaigala, G.V., (2021) 
  Spatial protein heterogeneity analysis in frozen tissues to evaluate tumor heterogeneity.
  PLOS ONE 16, e0259332. https://doi.org/10.1371/journal.pone.0259332
• Janša, V., Klančič, T., Pušić, M., Klein, M., Vrtačnik Bokal, E., Ban Frangež, H., Rižner, T.L., (2021) 
  Proteomic analysis of peritoneal fluid identified COMP and TGFBI as new candidate biomarkers for endometriosis.
  Sci Rep 11, 20870. https://doi.org/10.1038/s41598-021-00299-2
• Jarazo, J., Barmpa, K., Modamio, J., Saraiva, C., Sabaté‐Soler, S., Rosety, I., Griesbeck, A., Skwirblies, F., Zaffaroni, G., Smits, L.M., Su, J., Arias‐Fuenzalida, J., Walter, J., Gomez‐Giro, G., Monzel, A.S., Qing, X., Vitali, A., Cruciani, G., Boussaad, I., Brunelli, F., Jäger, C., Rakovic, A., Li, W., Yuan, L., Berger, E., Arena, G., Bolognin, S., Schmidt, R., Schröder, C., Antony, P.M.A., Klein, C., Krüger, R., Seibler, P., Schwamborn, J.C., (2021)
  Parkinson’s Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2‐Hydroxypropyl‐β‐CyclodextrinTreatment.
  Mov Disord mds.28810. https://doi.org/10.1002/mds.28810
• Kowtharapu, B.S., Damaraju, J., Singh, N.K., Ziebart, J., Bader, R., Koczan, D., Stachs, O., (2021)
  Analysis of the Differential Gene and Protein Expression Profiles of Corneal Epithelial Cells Stimulated with Alternating Current Electric Fields.
  Genes 12, 299. https://doi.org/10.3390/genes12020299
• Lange, C., Weber, A.M., Schmidt, R., Schroeder, C., Strowitzki, T., Germeyer, A., (2021)
  Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.
  PLOS ONE 16, e0248103. https://doi.org/10.1371/journal.pone.0248103

2020

• Boberg, E., Kadri, N., Winterling, J., Davies, L.C., Björklund, A., Msghina, M., Iacobaeus, E., Le Blanc, K., (2020) 
  Mental fatigue after allogeneic hematopoietic stem cell transplantation is associated with cognitive dysfunction, but not central nervous system inflammation.
  Haematologica 105, e310–e314. https://doi.org/10.3324/haematol.2019.225326
• Fernando, R., Wardelmann, K., Deubel, S., Kehm, R., Jung, T., Mariotti, M., Vasilaki, A., Gladyshev, V.N., Kleinridders, A., Grune, T., Castro, J.P., (2020)
  Low steady-state oxidative stress inhibits adipogenesis by altering mitochondrial dynamics and decreasing cellular respiration.
  Redox Biology 32, 101507. https://doi.org/10.1016/j.redox.2020.101507
• Fiorentino, F.P., Marchesi, I., Schröder, C., Schmidt, R., Yokota, J., Bagella, L., (2020)
  BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells.
  Int J Mol Sci 21. https://doi.org/10.3390/ijms21249595
• Yin, Y., Shelke, G.V., Lässer, C., Brismar, H., Lötvall, J., (2020)
  Extracellular vesicles from mast cells induce mesenchymal transition in airway epithelial cells.
  Respiratory Research 21, 101. https://doi.org/10.1186/s12931-020-01346-8

2019 and older

• Fultang, L., Gamble, L.D., Gneo, L., Berry, A.M., Egan, S.A., De Bie, F., Yogev, O., Eden, G.L., Booth, S., Brownhill, S., Vardon, A., McConville, C.M., Cheng, P.N., Norris, M.D., Etchevers, H.C., Murray, J., Ziegler, D.S., Chesler, L., Schmidt, R., Burchill, S.A., Haber, M., De Santo, C., Mussai, F., (2019)
  Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma.
  Cancer Res 79, 611–624. https://doi.org/10.1158/0008-5472.CAN-18-2139
• Reichman, H., Itan, M., Rozenberg, P., Yarmolovski, T., Brazowski, E., Varol, C., Gluck, N., Shapira, S., Arber, N., Qimron, U., Karo-Atar, D., Lee, J.J., Munitz, A., (2019)
  Activated Eosinophils Exert Antitumorigenic Activities in Colorectal Cancer.
  Cancer Immunol Res 7, 388–400. https://doi.org/10.1158/2326-6066.CIR-18-0494
• Kowtharapu, B.S., Murín, R., Jünemann, A.G.M., Stachs, O., (2018)
  Role of Corneal Stromal Cells on Epithelial Cell Function during Wound Healing.
  International Journal of Molecular Sciences 19, 464. https://doi.org/10.3390/ijms19020464
• Peiro, J.L., Oria, M., Aydin, E., Joshi, R., Cabanas, N., Schmidt, R., Schroeder, C., Marotta, M., Varisco, B.M., (2018)
  Proteomic profiling of tracheal fluid in an ovine model of congenital diaphragmatic hernia and fetal tracheal occlusion.
  Am J Physiol Lung Cell Mol Physiol 315, L1028–L1041. https://doi.org/10.1152/ajplung.00148.2018
• Thorenz, A., Derlin, K., Schröder, C., Dressler, L., Vijayan, V., Pradhan, P., Immenschuh, S., Jörns, A., Echtermeyer, F., Herzog, C., Chen, R., Rong, S., Bräsen, J.H., Kooten, C. van, Kirsch, T., Klemann, C., Meier, M., Klos, A., Haller, H., Hensen, B., Gueler, F., (2018)
  Enhanced activation of interleukin-10, heme oxygenase-1, and AKT in C5aR2-deficient mice is associated with protection from ischemia reperfusion injury–induced inflammation and fibrosis.
  Kidney International 94, 741–755. https://doi.org/10.1016/j.kint.2018.04.005
• Hamidi, Z., Tejero, E., Schmidt, R., Tucker, R., Pedro, A., (2017)
  Identification of potential blood-derived extracellular vesicles biomarkers to diagnose and predict distant metastases in ER+ breast cancer patients.
  bioRxiv 202291. https://doi.org/10.1101/202291
• Sass, F.A., Schmidt‐Bleek, K., Ellinghaus, A., Filter, S., Rose, A., Preininger, B., Reinke, S., Geissler, S., Volk, H.-D., Duda, G.N., Dienelt, A., (2017) 
  CD31+ Cells From Peripheral Blood Facilitate Bone Regeneration in Biologically Impaired Conditions Through Combined Effects on Immunomodulation and Angiogenesis.
  Journal of Bone and Mineral Research 32, 902–912. https://doi.org/10.1002/jbmr.3062
• Bakdash, G., Buschow, S.I., Gorris, M.A.J., Halilovic, A., Hato, S.V., Sköld, A.E., Schreibelt, G., Sittig, S.P., Torensma, R., Duiveman-de Boer, T., Schröder, C., Smits, E.L., Figdor, C.G., de Vries, I.J.M., (2016)
  Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.
  Cancer Res 76, 4332–4346. https://doi.org/10.1158/0008-5472.CAN-15-1695

Selected Scientific Publications by the Sciomics Team 

• Fiedler MK, Drechsel J, Schmidt R, Luppa PB, Bach NC, Sieber SA. (2023)
  Rapid Diagnostic Platform for Personalized Vitamin B6 Detection in Erythrocytes via PLP Cofactor Mimics.
  ACS Chem Biol. Jul 5. doi: 10.1021/acschembio.3c00279. Epub ahead of print.
• Galadima, M.; Kotova, I.; Schmidt, R.; Pastor, J.; Schröder, C.; Rodríguez-Gil, J.E.; del Alamo, M.M.R. (2023)
  Canine Mammary Neoplasia Induces Variations in the Peripheral Blood Levels of CD20, CD45RA, and CD99. 
  Int. J. Mol. Sci., 24, 9222. https://doi.org/10.3390/ijms24119222
• Hufnagel, K., Fathi, A., Stroh, N., Klein, M., Skwirblies, F., Girgis, R., Dahlke, C., Hoheisel, J. D., Lowy, C., Schmidt, R., Griesbeck, A., Merle, U., Addo, M. M., & Schröder, C. (2023)
  Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease. 
  Communications medicine, 3(1), 51. https://doi.org/10.1038/s43856-023-00283-z
• Marino, D., Pizzi, M., Kotova, I., Schmidt, R., Schröder, C., Guzzardo, V., Talli, I., Peroni, E., Finotto, S., Scapinello, G., Dei Tos, A.P., Piazza, F., Trentin, L., Zagonel, V., Piovan, E. (2022)
  High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients.
  Cancers 14. https://doi.org/10.3390/cancers14020338
• Jarazo, J., Barmpa, K., Modamio, J., Saraiva, C., Sabaté‐Soler, S., Rosety, I., Griesbeck, A., Skwirblies, F., Zaffaroni, G., Smits, L.M., Su, J., Arias‐Fuenzalida, J., Walter, J., Gomez‐Giro, G., Monzel, A.S., Qing, X., Vitali, A., Cruciani, G., Boussaad, I., Brunelli, F., Jäger, C., Rakovic, A., Li, W., Yuan, L., Berger, E., Arena, G., Bolognin, S., Schmidt, R., Schröder, C., Antony, P.M.A., Klein, C., Krüger, R., Seibler, P., Schwamborn, J.C. (2022) 
  Parkinson’s Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2‐Hydroxypropyl‐β‐CyclodextrinTreatment.
  Mov Disord mds.28810. https://doi.org/10.1002/mds.28810
• Pušić M, Klančič T, Knific T, Vogler A, Schmidt R, Schröder C, Lanišnik Rižner T. (2022)
  Antibody Arrays Identified Cycle-Dependent Plasma Biomarker Candidates of Peritoneal Endometriosis.
  J Pers Med. 12(6):852. doi: 10.3390/jpm12060852.
• Janša, V., Klančič, T., Pušić, M., Klein, M., Vrtačnik Bokal, E., Ban Frangež, H., Rižner, T.L. (2021) 
  Proteomic analysis of peritoneal fluid identified COMP and TGFBI as new candidate biomarkers for endometriosis.
  Sci Rep 11, 20870. https://doi.org/10.1038/s41598-021-00299-2
• Lange, C., Weber, A.M., Schmidt, R., Schroeder, C., Strowitzki, T., Germeyer, A. (2021)
  Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.
  PLOS ONE 16, e0248103. https://doi.org/10.1371/journal.pone.0248103
• Fiorentino, F.P., Marchesi, I., Schröder, C., Schmidt, R., Yokota, J., Bagella, L. (2020) 
  BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells.
  International Journal of Molecular Sciences 21, 9595. https://doi.org/10.3390/ijms21249595
• Fultang, L., Gamble, L.D., Gneo, L., Berry, A.M., Egan, S.A., Bie, F.D., Yogev, O., Eden, G.L., Booth, S., Brownhill, S., Vardon, A., McConville, C.M., Cheng, P.N., Norris, M.D., Etchevers, H.C., Murray, J., Ziegler, D.S., Chesler, L., Schmidt, R., Burchill, S.A., Haber, M., Santo, C.D., Mussai, F. (2019) 
  Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma.
  Cancer Res 79, 611–624. https://doi.org/10.1158/0008-5472.CAN-18-2139
• Thorenz, A., Derlin, K., Schröder, C., Dressler, L., Vijayan, V., Pradhan, P., Immenschuh, S., Jörns, A., Echtermeyer, F., Herzog, C., Chen, R., Rong, S., Bräsen, J.H., Kooten, C. van, Kirsch, T., Klemann, C., Meier, M., Klos, A., Haller, H., Hensen, B., Gueler, F. (2018) 
  Enhanced activation of interleukin-10, heme oxygenase-1, and AKT in C5aR2-deficient mice is associated with protection from ischemia reperfusion injury–induced inflammation and fibrosis.
  Kidney International 94, 741–755. https://doi.org/10.1016/j.kint.2018.04.005
• Peiro, J.L., Oria, M., Aydin, E., Joshi, R., Cabanas, N., Schmidt, R., Schroeder, C., Marotta, M., Varisco, B.M. (2018) 
  Proteomic profiling of tracheal fluid in an ovine model of congenital diaphragmatic hernia and fetal tracheal occlusion.
  American Journal of Physiology-Lung Cellular and Molecular Physiology 315, L1028–L1041. https://doi.org/10.1152/ajplung.00148.2018
• Bakdash, G., Buschow, S.I., Gorris, M.A.J., Halilovic, A., Hato, S.V., Sköld, A.E., Schreibelt, G., Sittig, S.P., Torensma, R., Boer, T.D., Schröder, C., Smits, E.L., Figdor, C.G., de Vries, I.J.M. (2016)
  Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.
  Cancer Res 76, 4332–4346. https://doi.org/10.1158/0008-5472.CAN-15-1695
• Kibat, J., Schirrmann, T., Knape, M.J., Helmsing, S., Meier, D., Hust, M., Schröder, C., Bertinetti, D., Winter, G., Pardes, K., Funk, M., Vala, A., Giese, N., Herberg, F.W., Dübel, S., Hoheisel, J.D. (2016).
  Utilisation of antibody microarrays for the selection of specific and informative antibodies from recombinant library binders of unknown quality.
  N Biotechnol 33, 574–581. https://doi.org/10.1016/j.nbt.2015.12.003
• Betzen, C., Alhamdani, M.S.S., Lueong, S., Schröder, C., Stang, A., Hoheisel, J.D. (2015) 
  Clinical proteomics: Promises, challenges and limitations of affinity arrays.
  PROTEOMICS – Clinical Applications 9, 342–347. https://doi.org/10.1002/prca.201400156
• Nijaguna, M.B., Schröder, C., Patil, V., Shwetha, S.D., Hegde, A.S., Chandramouli, B.A., Arivazhagan, A., Santosh, V., Hoheisel, J.D., Somasundaram, K. (2015) 
  Definition of a serum marker panel for glioblastoma discrimination and identification of Interleukin 1β in the microglial secretome as a novel mediator of endothelial cell survival induced by C-reactive protein.
  Journal of Proteomics 128, 251–261. https://doi.org/10.1016/j.jprot.2015.07.026
• Srinivasan, H., Allory, Y., Sill, M., Vordos, D., Alhamdani, M.S.S., Radvanyi, F., Hoheisel, J.D., Schröder, C. (2014) 
  Prediction of recurrence of non muscle-invasive bladder cancer by means of a protein signature identified by antibody microarray analyses.
  PROTEOMICS 14, 1333–1342. https://doi.org/10.1002/pmic.201300320
• Hoheisel, J.D., Alhamdani, M.S.S., Schröder, C. (2013) 
  Affinity-based microarrays for proteomic analysis of cancer tissues.
  PROTEOMICS – Clinical Applications 7, 8–15. https://doi.org/10.1002/prca.201200114
• Schröder, C., Srinivasan, H., Sill, M., Linseisen, J., Fellenberg, K., Becker, N., Nieters, A., Hoheisel, J.D. (2013) 
  Plasma protein analysis of patients with different B-cell lymphomas using high-content antibody microarrays.
  PROTEOMICS – Clinical Applications 7, 802–812. https://doi.org/10.1002/prca.201300048
• Alhamdani, M.S.S., Youns, M., Buchholz, M., Gress, T.M., Beckers, M.-C., Maréchal, D., Bauer, A., Schröder, C., Hoheisel, J.D. (2012) 
  Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines.
  Journal of Proteomics, 3747–3759. https://doi.org/10.1016/j.jprot.2012.04.042
• Alhamdani, M.S.S., Schröder, C., Hoheisel, J.D. (2010) 
  Analysis conditions for proteomic profiling of mammalian tissue and cell extracts with antibody microarrays.
  PROTEOMICS 10, 3203–3207. https://doi.org/10.1002/pmic.201000170
• Alhamdani, M.S.S., Schröder, C., Werner, J., Giese, N., Bauer, A., Hoheisel, J.D. (2010).
  Single-Step Procedure for the Isolation of Proteins at Near-Native Conditions from Mammalian Tissue for Proteomic Analysis on Antibody Microarrays.
  J. Proteome Res. 9, 963–971. https://doi.org/10.1021/pr900844q
• Schröder, C., Jacob, A., Tonack, S., Radon, T.P., Sill, M., Zucknick, M., Rüffer, S., Costello, E., Neoptolemos, J.P., Crnogorac-Jurcevic, T., Bauer, A., Fellenberg, K., Hoheisel, J.D. (2010).
  Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies.
  Molecular & Cellular Proteomics 9, 1271–1280. https://doi.org/10.1074/mcp.M900419-MCP200
• Sill, M., Schröder, C., Hoheisel, J.D., Benner, A., Zucknick, M. (2010).
  Assessment and optimisation of normalisation methods for dual-colour antibody microarrays.
  BMC Bioinformatics 11, 556. https://doi.org/10.1186/1471-2105-11-556
• Kusnezow, W., Banzon, V., Schröder, C., Schaal, R., Hoheisel, J.D., Rüffer, S., Luft, P., Duschl, A., Syagailo, Y.V. (2007).
  Antibody microarray-based profiling of complex specimens: systematic evaluation of labeling strategies.
  PROTEOMICS 7, 1786–1799. https://doi.org/10.1002/pmic.200600762

Presentations at Scientific Conferences 

2023

Alenazi, F., Schmidt, R., Schroder, C. et al (2023)
14 Metformin does not reverse the effect of pharmacological inhibition of protein phosphatase 2A on VE-cadherin in human microvascular endothelial cells
Heart 2023;109:A5. Scottish Cardiovascular Forum – 26th annual meeting 
https://doi.org/10.1136/heartjnl-SCF-2023.14

Ceton, L., Koedoot, E., Sijsenaar, T., Montero Garcia, M., Grillet, F., van der Valk, J., Weber, K., Schoenauer, R., Hufnagel, K., Schmidt, R., Stroh, N., Boekhoff, H., de Kroon, C., van Altena, A., van der Meer, D., Vader, W., Ottevanger, N., Kroep, J. (2023)
Interpretation of patient-specific ex vivo immunotherapy response for ovarian cancer [abstract].
Proceedings of the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics; 2023 Oct 11-15; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2023;22(12 Suppl):Abstract nr PR001. 
https://doi.org/10.1158/1535-7163.TARG-23-PR001

Kenzelmann, A., Boch, C., Schulz, M., Challagundla, M., Just, D.,Klein, M., Griesbeck, A., Schroeder, C. and Richter, M.(2023) Exploration of novel biomarkers for neurodegenerative diseases using ligand-binding assays. Alzheimer’sDement.2023;19(Suppl.14):e076362 , presented at the Alzheimer's Association International Conference (AAIC) 2023, July 16-20, Amsterdam, Netherlands; a collaboration of AbbVie and sciomics 
https://doi.org/10.1002/alz.076362

Kokol, M., Romano, A., Werner, E. et al (2023)
#383 BioEndoCar: identifying candidate biomarkers for diagnosis and prognosis of endometrial carcinoma using machine learning and artificial intelligence
International Journal of Gynecologic Cancer 2023;33:A368. ESGO 2023 Congress
https://doi.org/10.1136/ijgc-2023-ESGO.778

Swiatek-de Lange, M., Schroeder, C., Klein, M., Huang, J. and Strobl, M. (2023) 
Identification of biomarkers for prediction of dengue deterioration, presented at 6th Asia Dengue Summit (ADS 2023), 15-16 June 2023, Bangkok, Thailand; a collaboration of Roche Diagnostics and Sciomics

Xu, S., Schulz, M., Schmidt, R., Richter, M., Klein, M., Hufnagel, K., Schroeder, C. and Scolnick, J. (2023)
Increased monocyte activity identified in Alzheimer’s disease by in depth single-cell genomic and proteomic analysis. Alzheimer's Dement., 19: e071084 , presented at theAlzheimer's Association International Conference (AAIC) 2023, July 16-20, Amsterdam, Netherlands; a collaboration of Singleron Biotechnologies, AbbVie and Sciomics
https://doi.org/10.1002/alz.071084

2022

Schmidt, R., Schwamborn, J., Klein, M., Richter, M., Schulz, M. and Schroeder, C. (2022)
In-depth molecular profiling of Parkinson’s disease using advanced Minibrain models, presented at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD 2022), March 15-20, Barcelona, Spain, a collaboration of AbbVie, OrganoTherapeutics and Sciomics 

2021

Hafner, E., Smrkolj, Š., Romano, Werner, H. M. J., Semczuk, A., Kaminska, A., Adamiak-Godlewska, A., Fishman, D., Vilo, J., Lowy, C., Schröder, C., Janina Tokarz, J., Adamski, J., Weinberger, V., Bednaříková, M., Vinklerova, P., Ferrero, S., Barra, F., Takač, I., Knez, J., Lanišnik Rižner T. (2021)
BioEndoCar: in search of new Biomarkers for Diagnosis and Prognosis of Endometrial Carcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 464. 
https://doi.org/10.1158/1538-7445.AM2021-464

Schroeder, C., Schmidt, R., Klein, M., Griesbeck, A., Richter, M., Schulz, M. (2021)
Identification of new biomarker signatures for neurodegenerative diseases, presented at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD 2021), a collaboration of AbbVie and Sciomics  

Selected Patents with Contribution of our Microarray Platform

• WO2021175863A1: Method for diagnosis and/or prognosis of liver disease progression and risk of hepatocellular carcinoma and discovery of therapeutic compounds and targets to treat liver disease and cancer
• WO2021162554A1: Means and methods for determining mesenchymal stromal cell properties.
• US20210137912A1: s)-2-(1-(5-(cyclohexylcarbamoyl)-6-(propylthio)pyridin-2-yl)piperidin-3-yl)acetic acid for use in medicine
• EP2536844B1, US9551035B2: Means and methods for diagnosing pancreatic cancer
• EP2718720B1, US9678075B2: Prediction of recurrence for bladder cancer by a protein signature in tissue samples

| February 2023 | New Article: In the study Tintelnot et al. identified a microbiota-derived metabolite that has clinical implications in the treatment of pancreatic cancer. Sciomics supported the authors by a protein profiling study of tumours derived from a mouse model upon treatment with 3-IAA and Firinox.

Dr. Matthew Wright

Chief Scientific Officer, Kinarus Therapeutics AG, Basel, Switzerland

"We are a small biotech company without our own wet labs. Sciomics recommended a UK CRO that performed cell culture experiments for our studies. Sciomics seamlessly coordinated the transfer of the biologic materials to their facility and performed the scioCD panel to characterize cell surface markers and cytokines in cell lines treated with our small molecule drug candidates. The Sciomics data were instrumental in supporting our IP protection strategy. Their advice was very helpful and they worked with us to extract the most out of the data. We are very satisfied and highly recommend the Sciomics platform and the team."

Product: scioCD